272
Views
64
CrossRef citations to date
0
Altmetric
Research Article

Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis

, , , , , , , & show all
Pages 341-350 | Received 06 Oct 2009, Accepted 05 Jan 2010, Published online: 18 Feb 2010

References

  • Abdel-Mottaleb, M. M. A., Mortada, N. D., El-Shamy, A. A., Awad, G. A. S. (2009). Physically cross-linked polyvinyl alcohol for the topical delivery of fluconazole. Drug Dev Ind Pharm 35:311–320.
  • Agarwal, R., Katare, O. P., Vyas, S. P. (2001). Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 228:43–52.
  • Alekha, K. D., William, F. E. (2006). Fluconazole. In: Florey, K. (Ed.), Analytical profiles of drug substances and excipients (57-113). Academic Press, New York.
  • Bidkar, S., Jain, D., Padsalg, A., Patel, K., Mokale, V. (2007). Formulation development and evaluation of fluconazole gel in various polymer bases. As J Pharma 1:63–68.
  • Bouwstra, J. A., Honeywell-Nguyen, P. L., Gooris, G. S., Ponec, M. (2003). Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 42:1–36.
  • Calzavara-Pinton, P. G., Venturini, M., Sala, R. A. (2005). Comprehensive overview of photodynamic therapy in the treatment of superficial fungal infections of the skin. J Photochem Photobio B Bio 78:1–6.
  • Donnelly, R., McCarron, P., Tunney, M. (2008). Antifungal photodynamic therapy. Microbiol Res 163:1–12.
  • Fang, J. Y., Hong, C. T., Chiu, W. T., Wang, Y. Y. (2001). Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 219:61–72.
  • Foong, W. C., Harsanyi, B. B., Mezei, M. (1990). Biodisposition and histological evaluation of topically applied retinoic acid in liposomal, cream, and gel dosage forms. In: Hanin, I., Pepeu, G. (Eds.), Phospholipids ( pp 139–154). New York: Plenum Press.
  • Grant, S. M., Clissold, S. P. (1990). Fluconazole: a review of its pharmacodynamic and pharmacokinectic properties, and therapeutic potential in superficial and systemic mycoses. Drugs 39:877–916.
  • Gupta, P. N., Mishra, V., Rawat, A., Dubey, P., Mahor, S., Jain, S., Chatterji, D. P., Vyas, S. P. (2005). Noninvasive vaccine delivery in transfersomes, niosomes, and liposomes: a comparative study. Int J Pharm 293:73–82.
  • Ibrahim, A. A., Bosela, A. A., Ahmed, S. M., Mahrous, G. M. (2005). Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 59:485–490.
  • Jadhav, K. R., Kadam, V. J., Pisal, S. S. (2009). Formulation and evaluation of lecithin organogel for topical delivery of fluconazole. Curr Drug Deliv 6:174–183.
  • Junginger, H. E., Hofland, H. E. J., Bouwstra, J. A.(1991). Liposomes and niosomes interactions with human skin. Cosmet Toil 105:45–50.
  • Kim, M. K., Chung, S. J., Lee, M. H., Cho, A. R, Shim, C. K. (1997). Targeted and sustained delivery of hydrocortisone to normal and stratum corneum-removed skin without enhanced skin absorption using a liposome gel. J Contr Rel 46:243–251.
  • Laithy, H.M.E.I., EI-Shaboury, K. M. F. (2002). The development of cutina lipogels and gel microemulsion for topical administration of fluconazole. AAPS Pharmsci 3:1–9.
  • Lawrence, M. J., Chauhan, S., Lawrence, S. M., Barlow, D. J. (1996). The formation, characterization, and stability of nonionic surfactant vesicles. STP Pharm Sci 6:49–60.
  • Maebashi, K., Toyama, T., Uchida, K., Yamaguchi, H. (1995). A novel model of cutaneous candidiasis produced in prednisolone-treated guinea pigs. J Med Vet Mycol 19:390–392.
  • Manconi, M., Sinico, C., Valenti, D., Lai, F., Fadda, A. M. (2006). Niosomes as carriers for tretinoin III.A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J Pharm 311:11–19.
  • Manosroi, A., Jantrawut, P., Manosroi, J. (2008). Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 360:156–163.
  • Manosroi, A., Kongkaneramit, L., Manosroi,. J. (2004). Stability and transdermal absorption of topical amphotericin-B liposome formulations. Int J Pharm 270:279–86.
  • Manosroi, A., Wongtrakul, P., Manosroi, J., Sakai, H., Sugawara, F., Yuasa, M., Abe, M. (2003). Characterization of vesicles prepared with various nonionic surfactants mixed with cholesterol. Coll Sur B Bioint 30:129–138.
  • Mitragotri, S. (2000). In situ determination of partition and diffusion coefficients in the lipid bilayers of stratum corneum. Pharm Res 17:1026–1029.
  • Murdan, S. (2002). Drug delivery to the nail following topical application. Int J Pharm 236:1–26.
  • Ning, M., Guo, Y., Pan, H., Chen, X., Zhongwei, G. (2005). Preparation, in vitro and in vivo evaluation of liposomal/niosomal gel delivery systems for clotrimazole. Drug Dev Ind Pharm 31:375–383.
  • Ning, M., Guo, Y., Pan, H., Yu, H., Zhongwei, G. (2005). Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull 53:620–624.
  • Pavelic, Z., Skalko-Basnet, N., Schubert, R. (2001). Liposomal gels for vaginal drug delivery. Int J Pharm 219:139–149.
  • Qiu, Y., Gao, Y., Hu, K., Li, F. (2008). Enhancement of skin permeation of docetaxel: a novel approach combining microneedle and elastic liposomes. J Contr Rel 129:144–150.
  • Rai, S., Paliwal, R., Vaidya, B., Khatri, K., Goyal, A. K., Gupta, P. N., Vyas, S. P. (2008). Targeted delivery of doxorubicin via estrone-appended liposome. J Drug Targ 16:455–463.
  • Ramsdale, M. (2008). Programmed cell death in pathogenic fungi. Biochim Biophys Acta 1783:1369–1380.
  • Ruhnke, M., Hartwig, K., Kofla, G. (2008). New options for treatment of candidaemia in critically ill patients. Clin Microbiol Infect 14:46–54.
  • Satturwar, P. M., Khandare, J. N., Nande, V. S. (2001). Niosomal delivery of ketoconazole. Ind Drugs 38:620–624.
  • Schmid, M. H., Korting, H. C. (1996). Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Deliv Rev 18:335–342.
  • Schreier, H., Bouwstra, J. (1994). Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery. J Contr Rel 30:l–15.
  • Segal, E., Elad, D. (2006). Fungal vaccines and immunotherapy. J Med Mycol 16:134–151.
  • Shah, K. A., Date, A. A., Joshi, M. D., Patravale, V. B. (2007). Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery. Int J Pharm 345:163–171.
  • Shao, P., Huanga, L., Hsueh, P. (2007). Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicob Agents 30:487–495.
  • Singh, R., Vyas, S. P. (1996). Topical liposomal system for localized and controlled drug delivery. J Dermatol Sci 13:107–111.
  • Sinico, C., Manconi, M., Peppi, M., Lai, F., Valenti, D., Fadda, A. M. (2005). Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction. J Contr Rel 103:123–136.
  • Song, Y., Kim, C. (2006). Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials 27:271–280.
  • Soni, N., Wagstaff, A. (2005). Fungal infection: focus on critical care: antibiotics and ICU. Curr Anaes Crit Care16:231–241.
  • Tabbakhian, M., Tavakoli, N., Jaafari, M. R., Daneshamouza, S. (2006). Enhancement of follicular delivery of finasteride by liposomes and niosomes I. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 323:1–10.
  • Uchegbu, I. F., Vyas, S. P. (1998). Nonionic surfactant-based vesicles (niosomes) in drug delivery. Int J Pharm 172:33–70.
  • Wattananat, T., Akarawut, W. (2006). Validated HPLC method for the determination of fluconazole in human plasma. Biomed Chromat 20:1–3.
  • Williams, A. (2003). Transdermal and topical drug delivery, 1st ed. London: Pharmaceutical Press.
  • Williams, A. C., Barry, B. W. (1991). The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int J Pharm 74:157–168.
  • Yimei, J., Jolya, L., Omria, A. (2008). Liposomes as a carrier for gentamicin delivery: development and evaluation of the physicochemical properties. Int J Pharm 59:254–263.
  • Zhang, A. Y., Camp, W. L., Elewski, B. E. (2007). Advances in topical and systemic antifungals. Dermatol Clin 25:165–183.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.